153 related articles for article (PubMed ID: 16430074)
1. What news in urological cancer.
Lorusso V
Tunis Med; 2005 Dec; 83 Suppl 12():75-6. PubMed ID: 16430074
[No Abstract] [Full Text] [Related]
2. [Gemcitabine/cisplatin vs. MVAC. 5 year survival outcome of the phase III study of chemotherapy of advanced urothelial carcinoma in Germany].
Lehmann J; Retz M; Steiner G; Albers P; Jaeger E; Knuth A; Lippert C; Koser M; Stockamp K; Otto C; Melchior H; Fassmann C; Potratz C; Loch T; Derigs HG; Becker T; Kälble T; Piechota HJ; Hertle L; Weinknecht S; Weissbach L; Al-Mwalad M; Hamza A; Henss H; Brkovic D; Pomer S; Roloff J; Walz P; Muschter R; Tunn U; Winter E; Bub P; Kaldenbach U; Roth S; Brauers A; Jakse G; Richter AE; Wirth M; Hartlapp J; Van Ahlen H; Stöckle M
Urologe A; 2003 Aug; 42(8):1074-86. PubMed ID: 14513232
[TBL] [Abstract][Full Text] [Related]
3. [Neoadjuvant chemotherapy for urothelial tumors].
Culine S
Rev Prat; 2014 Dec; 64(10):1399. PubMed ID: 25665321
[No Abstract] [Full Text] [Related]
4. [Chemotherapy for urothelial infiltrating tumors].
Culine S
Cancer Radiother; 1998; 2(5):515-20. PubMed ID: 9868395
[TBL] [Abstract][Full Text] [Related]
5. [Gemcitabine and cisplatin therapy in advanced or metastatic urothelial cancer: comparison of side effect with MVAC (methotrexate, vinblastine, doxorubicin, and cisplatin)].
Ochi T; Ozawa A; Tanji N; Yanagihara Y; Yanagaki T; Miyauchi Y; Ikeda T; Shimamoto K; Toshino A; Sugawara T; Hamada H; Yokoyama M
Nihon Hinyokika Gakkai Zasshi; 2006 Sep; 97(6):777-81. PubMed ID: 17025209
[TBL] [Abstract][Full Text] [Related]
6. The comparison of oncologic outcomes between metastatic upper tract urothelial carcinoma and urothelial carcinoma of the bladder after cisplatin-based chemotherapy.
Hsieh MC; Chiang PH; Rau KM; Chen YY; Su YL; Huang CH
Urol Oncol; 2015 Nov; 33(11):495.e9-495.e14. PubMed ID: 26254698
[TBL] [Abstract][Full Text] [Related]
7. [Gemcitabine and pemetrexed in genito-urinary tumors treatment].
Fléchon A
Bull Cancer; 2007; 94 Spec No Actualites():S116-21. PubMed ID: 17845980
[TBL] [Abstract][Full Text] [Related]
8. Combination of gemcitabine and paclitaxel is a favorable option for patients with advanced or metastatic urothelial carcinoma previously treated with cisplatin-based chemotherapy.
Ikeda M; Matsumoto K; Tabata K; Minamida S; Fujita T; Satoh T; Iwamura M; Baba S
Jpn J Clin Oncol; 2011 Oct; 41(10):1214-20. PubMed ID: 21903707
[TBL] [Abstract][Full Text] [Related]
9. [Combination therapy consisting of gemcitabine, docetaxel and carboplatin as a second-line chemotherapy for patients with MVAC-treated metastatic urothelial carcinoma].
Inoue T; Obara T; Saito M; Kumazawa T; Narita S; Horikawa Y; Yuasa T; Tsuchiya N; Satoh S; Habuchi T
Hinyokika Kiyo; 2008 Sep; 54(9):581-5. PubMed ID: 18975570
[TBL] [Abstract][Full Text] [Related]
10. [The second-line chemotherapy for urological cancers].
Miki T; Mikami K; Mizutani Y
Gan To Kagaku Ryoho; 2005 Jan; 32(1):33-8. PubMed ID: 15675579
[TBL] [Abstract][Full Text] [Related]
11. Combination therapy consisting of gemcitabine, carboplatin, and docetaxel as an active treatment for advanced urothelial carcinoma.
Tsuruta H; Inoue T; Narita S; Horikawa Y; Saito M; Obara T; Numakura K; Maita S; Satoh S; Tsuchiya N; Habuchi T
Int J Clin Oncol; 2011 Oct; 16(5):533-8. PubMed ID: 21431341
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant gemcitabine plus carboplatin for locally advanced bladder cancer.
Iwasaki K; Obara W; Kato Y; Takata R; Tanji S; Fujioka T
Jpn J Clin Oncol; 2013 Feb; 43(2):193-9. PubMed ID: 23275643
[TBL] [Abstract][Full Text] [Related]
13. Randomized Phase III Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients with Muscle-invasive Bladder Cancer. Analysis of the GETUG/AFU V05 VESPER Trial Secondary Endpoints: Chemotherapy Toxicity and Pathological Responses.
Pfister C; Gravis G; Fléchon A; Soulié M; Guy L; Laguerre B; Mottet N; Joly F; Allory Y; Harter V; Culine S;
Eur Urol; 2021 Feb; 79(2):214-221. PubMed ID: 32868138
[TBL] [Abstract][Full Text] [Related]
14. Randomized phase II/III trial assessing gemcitabine/ carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer "unfit" for cisplatin-based chemotherapy: phase II--results of EORTC study 30986.
De Santis M; Bellmunt J; Mead G; Kerst JM; Leahy M; Maroto P; Skoneczna I; Marreaud S; de Wit R; Sylvester R
J Clin Oncol; 2009 Nov; 27(33):5634-9. PubMed ID: 19786668
[TBL] [Abstract][Full Text] [Related]
15. [Recent progress in the treatment for urothelial cancer].
Koga H; Naito S
Gan To Kagaku Ryoho; 2006 Feb; 33(2):164-70. PubMed ID: 16484850
[TBL] [Abstract][Full Text] [Related]
16. Second-line treatment of advanced transitional cell carcinoma of the urothelial tract.
Sternberg CN
Curr Opin Urol; 2001 Sep; 11(5):523-9. PubMed ID: 11493775
[TBL] [Abstract][Full Text] [Related]
17. The present and future of combination chemotherapy in bladder cancer.
Culine S
Semin Oncol; 2002 Jun; 29(3 Suppl 9):32-9. PubMed ID: 12094336
[TBL] [Abstract][Full Text] [Related]
18. Current status of systemic chemotherapy for octogenarians with advanced urothelial cancer in Japan: a Japanese multi-institutional study (CURE study).
Matsui Y; Ogawa O; Ishitsuka R; Miyazaki J; Inoue T; Kageyama S; Sugimoto M; Mitsuzuka K; Shiraishi Y; Kinoshita H; Wakeda H; Nomoto T; Kikuchi E; Fujie K; Keino N; Nishiyama H
Int J Clin Oncol; 2016 Dec; 21(6):1142-1149. PubMed ID: 27349431
[TBL] [Abstract][Full Text] [Related]
19. The outcome of elderly patients with advanced urothelial carcinoma after platinum-based combination chemotherapy.
Bamias A; Efstathiou E; Moulopoulos LA; Gika D; Hamilos G; Zorzou MP; Kakoyiannis C; Kastritis E; Bozas G; Papadimitriou C; Dimopoulos MA
Ann Oncol; 2005 Feb; 16(2):307-13. PubMed ID: 15668289
[TBL] [Abstract][Full Text] [Related]
20. Different Chemotherapy Regimens in the Management of Advanced or Metastatic Urothelial Cancer: a Bayesian Network Meta-Analysis of Randomized Controlled Trials.
Wang Y; Xu L; Meng X; Qin Z; Wang Y; Chen C; Wang Y; Zhou X; Zhang Q; Xia J; Song N
Cell Physiol Biochem; 2018; 50(1):1-14. PubMed ID: 30293075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
